Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag ALK's peanut allergy treatment shows promise in early clinical trial, with plans for further testing.

flag ALK's clinical trial for a peanut allergy treatment showed positive results, with the sublingual immunotherapy tablet proving safe and tolerable in a trial of 30 patients. flag Mild side effects were common but transient. flag The next phase, involving about 125 patients, will test two dosing regimens and is set to conclude in 2026. flag Success could lead to further development and potential approval for treating peanut allergies, which affect up to 1.5 million children and adolescents in the US.

3 Articles